LivTech Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

LivTech General Information

Description

Operator of a bio technology company intended to develop antibodies for cancer stem cell antigens. The company's activities include developing antibodies, antibiotics and stem cells for various diseases.

Contact Information

Website
www.livtech.co.jp
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Teikyo University Biotechnology Research Centre 1st Floor
  • 907 Nogawa, Miyamae
  • Kawasaki, 216-0001
  • Japan
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Other Pharmaceuticals and Biotechnology
Acquirer
Chiome Bioscience
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Teikyo University Biotechnology Research Centre 1st Floor
  • 907 Nogawa, Miyamae
  • Kawasaki, 216-0001
  • Japan

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LivTech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LivTech‘s full profile, request access.

Request a free trial

LivTech Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

LivTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-WO2013077458-A1 Anti-human trop-2 antibody having antitumor activity in vivo Active 22-Nov-2011
JP-WO2011145744-A1 Anti-human trop-2 antibody having antitumor activity in vivo Active 17-May-2010
JP-5615169-B2 Anti-human dlk-1 antibody having antitumor activity in vivo Active 17-Mar-2008
JP-WO2009116670-A1 Anti-human dlk-1 antibody having antitumor activity in vivo Active 17-Mar-2008
JP-5219827-B2 Anti-human dlk-1 antibody having antitumor activity in vivo Inactive 10-Nov-2006 C07K16/28
To view LivTech’s complete patent history, request access »

LivTech FAQs

  • When was LivTech founded?

    LivTech was founded in 2004.

  • Where is LivTech headquartered?

    LivTech is headquartered in Kawasaki, Japan.

  • What industry is LivTech in?

    LivTech’s primary industry is Biotechnology.

  • Is LivTech a private or public company?

    LivTech is a Private company.

  • What is LivTech’s current revenue?

    The current revenue for LivTech is .

  • When was LivTech acquired?

    LivTech was acquired on 13-Mar-2015.

  • Who acquired LivTech?

    LivTech was acquired by Chiome Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »